Preparing for your next doctor's visit?
Have you ever left an appointment and realized you forgot to discuss an MS symptom?
Check out My Conversation Starter
Here for you 24/7
Call MS LifeLines toll-free at
1-877-447-3243 anytime, day or night.
A live representative is always available to take your call.
MS Fact
More than twice as many women as men have MS.
Thinking about changing therapy?
During the course of your treatment for relapsing multiple sclerosis, your doctor may determine that your current MS therapy is no longer the best choice for you.
Because there isn't one therapy that works for every person, sometimes people with relapsing MS are prescribed different therapies before finding the therapy that works best for them.
Some reasons for changing MS treatments:
- Doctor believes current therapy isn't working
- Looking for more affordable access to therapy
- Having trouble staying on therapy because of the severity of side effects
- Looking for additional support services to help start and stay on therapy
- Seeking a treatment that fits with lifestyle
Did you know? Some DMDs provide support services. Rebif® (interferon beta-1a) not only has proven efficacy and a well-established safety profile but also offers product features designed for convenience and the MS LifeLines® comprehensive network of support to help you start and stay on therapy.
Learn more about the benefits of Rebif.
Indication
- Rebif is used to treat relapsing forms of MS to decrease the frequency of relapses and delay the occurrence of some of the physical disability that is common in people with MS.
- Rebif is not approved for treatment of chronic progressive MS.
- Rebif is available in 22 mcg and 44 mcg prefilled, preassembled syringes and a titration pack by prescription only.
Important Safety Information
Before beginning treatment, patients should discuss with their doctor the potential benefits and risks associated with Rebif.
Let your doctor know:
- If you have a history of depression, seizures, liver disease, thyroid problems, or blood cell count or bleeding problems, or if you have had previous allergic reactions to medications.
- About all medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Rebif and other medicines may affect each other, causing serious side effects.
- Before you take any new medicines.
Rebif is not recommended for women who are or plan to become pregnant.
Potential serious side effects of Rebif include:
- Depression and risk of suicide
- Liver problems
- Risk to pregnancy
- Injection-site problems
- Severe allergic reactions. Allergic reactions are rare and may be associated with difficulty in breathing and loss of consciousness, which require immediate medical attention.
The most common side effects with Rebif are:
- Injection-site reactions
- Flu-like symptoms (fever, chills, muscle aches, tiredness)
- Depression
- Abdominal pain
- Increased liver enzymes
- Blood cell count decreases
Let your doctor know if you have any of these symptoms or feel sad, tired, hot or cold, or experience hives, rashes, bruising, yellowing of the skin, or a change in body weight (gain or loss).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This information is not intended to replace discussions with your doctor. For additional information about Rebif, please consult the Prescribing Information and Medication Guide and talk to your doctor. You can also call toll-free 1-877-44-REBIF (1-877-447-3243). Rebif is available by prescription only.
MS LifeLines is an educational support service for people living with MS and their families. MS LifeLines and MS LifeLines Ambassadors are sponsored by EMD Serono, Inc. and Pfizer Inc. Speakers and MS LifeLines Ambassadors who participate in Talk MS or in live events are sponsored by EMD Serono, Inc. and Pfizer Inc. Rebif, Rebiject II and MS LifeLines are registered trademarks and the Rebif logo is a trademark of EMD Serono, Inc. or its affiliates.
Brought to you by EMD Serono, Inc. and Pfizer Inc, the co-marketers of Rebif® (interferon beta-1a) in the US.
This information is intended only for residents of the United States.
Copyright © 2010 EMD Serono, Inc. All rights reserved.
EMD Serono, Inc., One Technology Place, Rockland, MA 02370
